If a person carries a mutation(s) in the DPYD gene, certain chemotherapies (fluorouracil (5-FU) or capecitabine (Xeloda or ...

Researchers have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with collagenous structure, or MARCO. Their study shows that blocking MARCO in ...

Researchers from Moffitt Cancer Center have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with collagenous structure, or MARCO.

Researchers from Moffitt Cancer Center have found a new way to boost cancer immunotherapy by targeting a protein called ...

Researchers from Moffitt Cancer Center have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with collagenous structure, or MARCO. Their study, published ...

Josh Carpenter, who filled prominent positions with Southern Research and the city of Birmingham, has joined a Florida cancer research organization. Carpenter has been named president of Tampa-based ...

Josh Carpenter, who will serve as the president of Speros and Moffitt's chief integration officer, will lead the 775-acre ...

The BriefAdvocates with Moffitt Cancer Center will meet with Florida lawmakers in Tallahassee on Wednesday.The trip is an ...

Dozens of advocates with Moffitt Cancer Center are meeting with Florida lawmakers in Tallahassee on Wednesday as part of their push for continued cancer research funding at the state level. FOX 13’s ...

TAMPA, Fla. (WFLA) — Dozens of riders will finish a more than 300-mile bike from Tampa to Tallahassee. It is part of Moffitt ...

Josh Carpenter, PhD, has been named vice president and chief integration officer at Tampa, Fla.-based Moffitt Cancer Center, and president of Speros, a Land O' Lakes, Fla.-based research facility and ...